ADMA Biologics to Present at Upcoming Investor Conferences
Aug 23, 2017 11:38 am UTC| Business
RAMSEY, N.J., Aug. 23, 2017 -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), a vertically integrated biopharmaceutical and specialty immunoglobulin company that develops, manufactures and markets...
Incysus Scientific Co-Founder to Present at Immuno-Oncology Summit
Aug 23, 2017 11:30 am UTC| Business
HAMILTON, Bermuda, Aug. 23, 2017 -- Incysus, Ltd, a biopharmaceutical company focused on delivering an innovative γδ T cell immunotherapy for the treatment of cancers, announced that its collaborator and scientific...
Gentex Announces Quarterly Cash Dividend and Additional Share Repurchase Authorization
Aug 23, 2017 11:30 am UTC| Business
ZEELAND, Mich., Aug. 23, 2017 -- Gentex Corporation (NASDAQ:GNTX), the Zeeland, Michigan-based manufacturer of automotive automatic-dimming rearview mirrors, automotive electronics, dimmable aircraft windows and fire...
Aug 23, 2017 11:30 am UTC| Business
PLAINVIEW, N.Y., Aug. 23, 2017 -- NeuLion, Inc. (TSX:NLN), a leading technology product and service provider specializing in the broadcasting, distribution and monetization of live and on-demand digital video content to...
Diffusion Pharmaceuticals Names William Hornung Chief Business Officer
Aug 23, 2017 11:30 am UTC| Business
CHARLOTTESVILLE, Va., Aug. 23, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development of novel small molecule therapeutics...
Aug 23, 2017 11:05 am UTC| Business
Once Completed and Fully Licensed, Isla Verde District of Carolina Will Be Home to Company’s New Dispensary Isla Verde Is Popular Tourist Destination With Large Concentration of Restaurants, Hotels and Luxury Homes SAN...
Alligator Bioscience AB: Interim report January - June 2017
Aug 23, 2017 11:01 am UTC| Business
Alligator Bioscience AB ((Nasdaq Stockholm; ATORX) Interim report January - June 2017 "We have advanced our project pipeline significantly during the second quarter. The immuno-oncology antibody ATOR-1017 moved into...